Asolution Pharmaceuticals Private Limited, a active private limited company, was established on 07 May 2010 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24100MH2010PTC202851. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.89 Cr.
It upholds a compliant status. Employing 119 professional, Its leadership includes Nandkumar Kashinath Chodankar (Director), Laxmi Nandkumar Chodankar (Director). It holds ₹24.96 Cr open charges and ₹37.55 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 11- A, Mittal Chambers, Nariman Point, Mumbai, Maharashtra, 400021.
U24100MH2010PTC202851
202851
07 May 2010
₹5.00 Cr
₹4.89 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Asolution Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nandkumar Kashinath Chodankar | Director | 07 May 2010 | Current |
| Laxmi Nandkumar Chodankar | Director | 07 May 2010 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Asolution Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.49% decrease. The company also saw a substantial fall in profitability, with a 128.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 69.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Asolution Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹249,600,000.00
₹375,504,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Aug 2020 | Others | ₹3.47 Cr | Open |
| 17 Nov 2015 | Others | ₹21.49 Cr | Open |
| 04 Jan 2023 | Others | ₹3.00 Cr | Satisfied |
| 29 Jan 2022 | Others | ₹4.20 M | Satisfied |
| 06 Jun 2020 | Others | ₹6.00 M | Satisfied |
Explore comprehensive loan charge details -
Asolution Pharmaceuticals has a workforce of 119 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Asolution Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asolution Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Asolution Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Asolution Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge registered on 04 Jan 2023 via Charge ID 100669829 with Others was fully satisfied on 10 Jul 2023. was documented.
Progress on A charge registered on 29 Jan 2022 via Charge ID 100542544 with Others was fully satisfied on 10 Jul 2023. was documented.
Progress on A charge registered on 28 Aug 2014 via Charge ID 10547757 with Others was fully satisfied on 10 Jul 2023. was documented.
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100669829 was registered on 04 Jan 2023. was recorded as a recent event.
The CIN of Asolution Pharmaceuticals Private Limited is U24100MH2010PTC202851.
Asolution Pharmaceuticals Private Limited is headquartered at 11- A, Mittal Chambers, Nariman Point, Mumbai, Maharashtra, 400021.
Asolution Pharmaceuticals Private Limited was incorporated on 07 May 2010.
The current directors of Asolution Pharmaceuticals Private Limited are
The primary industry of Asolution Pharmaceuticals Private Limited is Manufacturing.
Asolution Pharmaceuticals Private Limited is unlisted.
The authorized capital of Asolution Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.89 Cr.
The compliance status of Asolution Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX